InsidersTradesSigma
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
No signal scores available.
Discover the complete record of transactions filed by Lee Byoung Chul, Chief Executive Officer. Insider active across 2 companies, notably 카나프테라퓨틱스. Cumulatively, 3 reports have been logged. Regulator: DART (FSS). The full history is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
LEE BYOUNG CHUL is the CEO of 카나프테라퓨틱스, a company specializing in biotechnology. He is responsible for the overall strategy and product development. LEE BYOUNG CHUL is committed to positioning the company as a leader in innovative therapies.